Geetha P. Bansal

Array ( [id] => 4324701 [patent_doc_number] => 06312718 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Vaccine for B-cell malignancies' [patent_app_type] => 1 [patent_app_number] => 9/125376 [patent_app_country] => US [patent_app_date] => 1998-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6348 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312718.pdf [firstpage_image] =>[orig_patent_app_number] => 125376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1598800 [patent_doc_number] => 06475490 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Compositions and methods for promoting tissue repair using heat shock proteins' [patent_app_type] => B1 [patent_app_number] => 09/174884 [patent_app_country] => US [patent_app_date] => 1998-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 12729 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475490.pdf [firstpage_image] =>[orig_patent_app_number] => 09174884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4253029 [patent_doc_number] => 06203787 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Treating tumors using implants comprising combinations of allogeneic cells' [patent_app_type] => 1 [patent_app_number] => 9/169561 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20361 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/203/06203787.pdf [firstpage_image] =>[orig_patent_app_number] => 169561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1445915 [patent_doc_number] => 06368593 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Enhanced immunogenic cell populations prepared using H2 receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 09/169345 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9224 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368593.pdf [firstpage_image] =>[orig_patent_app_number] => 09169345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4273825 [patent_doc_number] => 06245885 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Bax-mediated apoptosis modulating reagents and methods' [patent_app_type] => 1 [patent_app_number] => 9/166028 [patent_app_country] => US [patent_app_date] => 1998-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 12074 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245885.pdf [firstpage_image] =>[orig_patent_app_number] => 166028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4352339 [patent_doc_number] => 06291430 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Mage-3 peptides presented by HLA class II molecules' [patent_app_type] => 1 [patent_app_number] => 9/166448 [patent_app_country] => US [patent_app_date] => 1998-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 28500 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291430.pdf [firstpage_image] =>[orig_patent_app_number] => 166448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1476714 [patent_doc_number] => 06451316 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-17 [patent_title] => 'Methods for generating antigen-reactive T cells in vitro' [patent_app_type] => B1 [patent_app_number] => 09/166401 [patent_app_country] => US [patent_app_date] => 1998-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18884 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 31 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/451/06451316.pdf [firstpage_image] =>[orig_patent_app_number] => 09166401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4281975 [patent_doc_number] => 06267959 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Monoclonal antibodies having property of causing apoptosis and used as anticancer agents' [patent_app_type] => 1 [patent_app_number] => 9/154498 [patent_app_country] => US [patent_app_date] => 1998-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 5792 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/267/06267959.pdf [firstpage_image] =>[orig_patent_app_number] => 154498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1548483 [patent_doc_number] => 06399063 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Monoclonal antibodies directed to the HER2 receptor' [patent_app_type] => B1 [patent_app_number] => 09/152654 [patent_app_country] => US [patent_app_date] => 1998-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 10660 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399063.pdf [firstpage_image] =>[orig_patent_app_number] => 09152654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4313927 [patent_doc_number] => 06248327 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis' [patent_app_type] => 1 [patent_app_number] => 9/152160 [patent_app_country] => US [patent_app_date] => 1998-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 31 [patent_no_of_words] => 25670 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248327.pdf [firstpage_image] =>[orig_patent_app_number] => 152160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4289159 [patent_doc_number] => 06268411 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-31 [patent_title] => 'Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses' [patent_app_type] => 1 [patent_app_number] => 9/150622 [patent_app_country] => US [patent_app_date] => 1998-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 31 [patent_no_of_words] => 14426 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/268/06268411.pdf [firstpage_image] =>[orig_patent_app_number] => 150622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4297686 [patent_doc_number] => 06187312 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of infectious diseases' [patent_app_type] => 1 [patent_app_number] => 9/150040 [patent_app_country] => US [patent_app_date] => 1998-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18824 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187312.pdf [firstpage_image] =>[orig_patent_app_number] => 150040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240631 [patent_doc_number] => 06136315 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Compositions and methods using complexes of heat shock protein 70 and antigenic molecules for the treatment and prevention of neoplastic diseases' [patent_app_type] => 1 [patent_app_number] => 9/150204 [patent_app_country] => US [patent_app_date] => 1998-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18336 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136315.pdf [firstpage_image] =>[orig_patent_app_number] => 150204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4079974 [patent_doc_number] => 06162436 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of neoplastic diseases' [patent_app_type] => 1 [patent_app_number] => 9/150041 [patent_app_country] => US [patent_app_date] => 1998-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 18 [patent_no_of_words] => 18445 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162436.pdf [firstpage_image] =>[orig_patent_app_number] => 150041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4230848 [patent_doc_number] => 06143299 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Compositions and methods using complexes of heat shock protein gp96 and antigenic molecules for the treatment and prevention of infectious diseases' [patent_app_type] => 1 [patent_app_number] => 9/150203 [patent_app_country] => US [patent_app_date] => 1998-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18450 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143299.pdf [firstpage_image] =>[orig_patent_app_number] => 150203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4163695 [patent_doc_number] => 06139841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Compositions and methods using complexes of heat shock protein 70 and antigenic molecules for the treatment and prevention of infectious diseases' [patent_app_type] => 1 [patent_app_number] => 9/150039 [patent_app_country] => US [patent_app_date] => 1998-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18436 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/139/06139841.pdf [firstpage_image] =>[orig_patent_app_number] => 150039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407258 [patent_doc_number] => 06309855 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs' [patent_app_type] => 1 [patent_app_number] => 9/144914 [patent_app_country] => US [patent_app_date] => 1998-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 50 [patent_no_of_words] => 18080 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309855.pdf [firstpage_image] =>[orig_patent_app_number] => 144914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4372596 [patent_doc_number] => 06303127 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Treatment of disease states' [patent_app_type] => 1 [patent_app_number] => 9/132353 [patent_app_country] => US [patent_app_date] => 1998-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4108 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303127.pdf [firstpage_image] =>[orig_patent_app_number] => 132353 [rel_patent_id] =>[rel_patent_doc_number] =>)